Advertisement

The Basic Sequence of Injury in Acute Skin GVHD

  • Teresa S. HyunEmail author
  • Shiva Khoobyari
  • Oliver H. Chang
Chapter

Abstract

Development of maculopapular rashes in patients <100 days post-hematopoietic stem cell transplantation (HSCT) is common. Evaluation often includes skin biopsy for the diagnosis of acute GVHD (aGVHD). The Lerner grading system for cutaneous aGVHD incorporates apoptotic keratinocytes, pattern of inflammation, and degree of epidermal destruction. The timing of the skin biopsy and the severity of the rash will influence the differential diagnosis, which includes drug reaction, chemotherapy toxicity, engraftment syndrome, and infections. More severe reactions raise a differential diagnosis of erythema multiforme, Stevens-Johnson syndrome (SJS), and, SJS’s more severe form, toxic epidermal necrolysis (TEN). Cases of classic aGVHD superimposed with cGVHD are classified as overlap syndrome. The immunopathogenesis of aGVHD involves the interaction of donor T lymphocytes with host tissue, along with costimulatory pathways, cytokines, and other inflammatory cell types.

Keywords

Acute cutaneous GVHD Lerner grading system Late onset of acute GVHD Overlap acute and chronic GVHD 

References

  1. 1.
    Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E, Moresi JM, Greenson J, Janin A, Martin PJ, McDonald G, Flowers MED, Turner M, Atkinson J, Lefkowitch J, Washington MK, Prieto VG, Kim SK, Argenyi Z, Diwan AH, Rashid A, Hiatt K, Couriel D, Schultz K, Hymes S, Vogelsang GB. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology working group report. Biol Blood Marrow Transplant. 2006;12(1):31–47.CrossRefGoogle Scholar
  2. 2.
    Marra DE, Mckee PH, Nghiem P. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease. J Am Acad Dermatol. 2004;51(4):543–6.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Spitzer TR. Engraftment syndrome: double-edged sword of hematopoietic cell transplants. Bone Marrow Transplant. 2015;50(4):469–75.PubMedCrossRefGoogle Scholar
  4. 4.
    Narimatsu H, Terakura S, Matsuo K, et al. Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults. Bone Marrow Transplant. 2007;39(1):31–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Lerner KG, Kao GF, Storb R, Buckner CD, Clift RA, Thomas ED. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc. 1974;6(4):367–71.PubMedGoogle Scholar
  6. 6.
    Shulman HM, Cardona DM, Greenson JK, et al. NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report. Biol Blood Marrow Transplant. 2015;21(4):589–603.PubMedPubMedCentralCrossRefGoogle Scholar
  7. 7.
    Loeb KR, Yeung CC, Shulman HM. Pathology of hematopoietic cell transplantation. In: Forman SJ, Negrin RS, Antin JH, Appelbaum FR, editors. Thomas’ hematopoietic cell transplantation, vol. 1. 5th ed. Chichester, West Sussex: John Wiley & Sons, Ltd; 2016. p. 292–328.CrossRefGoogle Scholar
  8. 8.
    Hymes SR, Simonton SC, Farmer ER, Beschorner WB, Tutschka PJ, Santos GW. Cutaneous busulfan effect in patients receiving bone-marrow transplantation. J Cutan Pathol. 1985;12(2):125–9.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Li N, Guthrie KA, Storer BE, et al. Keratinocyte dysplasia in hematopoietic stem cell transplantation recipients in the day-28-to-84 posttransplantation period. Biol Blood Marrow Transplant. 2012;18(8):1281–6.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945–56.CrossRefGoogle Scholar
  11. 11.
    Vigorito AC, Campregher PV, Storer BE, et al. Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD. Blood. 2009;114(3):702–8.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Arora M, Cutler CS, Jagasia MH, et al. Late acute and chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2016;22(3):449–55.PubMedCrossRefGoogle Scholar
  13. 13.
    Pidala J, Vogelsang G, Martin P, et al. Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study. Haematologica. 2012;97(3):451–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Sale GE, Lerner KG, Barker EA, Shulman HM, Thomas ED. The skin biopsy in the diagnosis of acute graft-versus-host disease in man. Am J Pathol. 1977;89(3):621–36.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Firoz BF, Lee SJ, Nghiem P, Qureshi AA. Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis. Arch Dermatol. 2006;142(2):175–82.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Zeiser R, Blazar BR. Acute graft-versus-host disease – biologic process, prevention, and therapy. N Engl J Med. 2017;377(22):2167–79.PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Romano M, Tung SL, Smyth LA, Lombardi G. Treg therapy in transplantation: a general overview. Transpl Int. 2017;30(8):745–53.PubMedCrossRefGoogle Scholar
  18. 18.
    Vander Lugt MT, Braun TM, Hanash S, et al. ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med. 2013;369(6):529–39.PubMedPubMedCentralCrossRefGoogle Scholar
  19. 19.
    Abu Zaid M, Wu J, Wu C, et al. Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT. Blood. 2017;129(2):162–70.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Harris AC, Young R, Devine S, et al. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium. Biol Blood Marrow Transplant. 2016;22(1):4–10.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Teresa S. Hyun
    • 1
    • 2
    • 3
    Email author
  • Shiva Khoobyari
    • 1
  • Oliver H. Chang
    • 1
    • 4
  1. 1.Clinical Research DivisionFred Hutchinson Cancer Research CenterSeattleUSA
  2. 2.Department of PathologyUniversity of Washington School of MedicineSeattleUSA
  3. 3.Pathology SectionSeattle Cancer Care AllianceSeattleUSA
  4. 4.Department of Anatomic Pathology/DermatopathologyVA Puget Sound Health Care SystemSeattleUSA

Personalised recommendations